hat
Anplis de sa, depi oktòb 2008, Ewopeyen Medikaman Ajans la te rekòmande ke Rimonabant dwe restriksyon pou itilize ak medikaman. Youn nan rezon pou sa a se risk pou yo lakòz pwoblèm mantal tankou depresyon. Lè sa a, gen manifakti a retire dwòg la soti nan mache a.
eng
In addition, since October 2008, the European Medicines Agency has recommended that rimonabant be restricted for use with medications. One reason for this is the risk of causing mental disorders such as depression. Then the manufacturer has withdrawn the drug from the market.